These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10549282)

  • 1. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.
    Sun Y; Liu X; Eaton EN; Lane WS; Lodish HF; Weinberg RA
    Mol Cell; 1999 Oct; 4(4):499-509. PubMed ID: 10549282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines.
    Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF
    J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
    Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
    J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B).
    Feng XH; Liang YY; Liang M; Zhai W; Lin X
    Mol Cell; 2002 Jan; 9(1):133-43. PubMed ID: 11804592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling.
    Sun Y; Liu X; Ng-Eaton E; Lodish HF; Weinberg RA
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12442-7. PubMed ID: 10535941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion proteins of retinoid receptors antagonize TGF-beta-induced growth inhibition of lung epithelial cells.
    La P; Morgan TA; Sykes SM; Mao H; Schnepp RW; Petersen CD; Hua X
    Oncogene; 2003 Jan; 22(2):198-210. PubMed ID: 12527889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling.
    Ueki N; Hayman MJ
    J Biol Chem; 2003 Aug; 278(35):32489-92. PubMed ID: 12857746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis.
    Medrano EE
    Oncogene; 2003 May; 22(20):3123-9. PubMed ID: 12793438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
    Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
    J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
    Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
    Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different sensitivity of the transforming growth factor-beta cell cycle arrest pathway to c-Myc and MDM-2.
    Blain SW; Massagué J
    J Biol Chem; 2000 Oct; 275(41):32066-70. PubMed ID: 10906337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Myc and TGF-beta signalling in cell-cycle control.
    Amati B
    Nat Cell Biol; 2001 May; 3(5):E112-3. PubMed ID: 11331894
    [No Abstract]   [Full Text] [Related]  

  • 17. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.
    Warner BJ; Blain SW; Seoane J; Massagué J
    Mol Cell Biol; 1999 Sep; 19(9):5913-22. PubMed ID: 10454538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
    Stroschein SL; Wang W; Zhou S; Zhou Q; Luo K
    Science; 1999 Oct; 286(5440):771-4. PubMed ID: 10531062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
    Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
    Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.